“We’re honored to receive this endorsement from the EIC Accelerator. This support will catalyze our next phase of innovation—building on the success of our initial product and unlocking new frontiers in immuno-oncology, FFPE analysis, and translational research. The EIC’s blended finance instrument is uniquely suited for visionary deep tech platforms like PNA that require both technical and commercial de-risking.
The expertise and dedication of GAEU Consulting were instrumental in securing this highly competitive funding, guiding us through the intricate application process with unparalleled professionalism. Their strategic approach and deep knowledge of the EIC Accelerator framework have been invaluable. For any life science deep tech company aiming to navigate the complexities of European funding opportunities, GAEU is an outstanding partner and highly recommended.”

Simon Fredriksson, CEO and Co-founder of Pixelgen Technologies

"We are honored to receive this prestigious funding from the EIC Accelerator, which recognizes ACD856's groundbreaking potential. This support will accelerate our clinical development and bring us closer to delivering a transformative therapy for Alzheimer's patients. The expertise and dedication of GAEU Consulting were instrumental in securing this highly competitive funding, guiding us through the intricate application process with unparalleled professionalism. Their strategic approach and deep knowledge of the EIC Accelerator framework have been invaluable, and we highly recommend GAEU Consulting to any company seeking to navigate the complexities of European funding opportunities."

Martin Jönsson, CEO of AlzeCure Pharma

“Securing the maximum funding available under the EIC Accelerator program highlights the innovative potential of PN6047. We are deeply thankful for GAEU Consulting’s professional assistance. Their expertise was invaluable and we highly recommend GAEU Consulting as a trusted advisor for the EIC Accelerator programme. The support from Horizon Europe will be crucial in advancing our clinical trials and bringing this much-needed pain relief solution to patients. This award, together with new upcoming investors, positions PN6047 as a potential pivotal treatment in neuropathic pain, ready to advance to the next stages of development.”

Per von Mentzer, CEO of PharmNovo

"The loan agreement with EIB further validates BrainCool’s cutting-edge technology, underpinning our goal to become a major player in the medical device market. This agreement supports our ambitious plan to develop an extensive clinical pipeline of groundbreaking therapies, initially focusing on stroke, then expanding to sudden cardiac arrest and oncology. Throughout this process, GAEU Consulting has offered invaluable support, including strategic project advice, assistance during due diligence, and financial modelling expertise. We strongly recommend GAEU as a highly experienced EIB advisor."

Martin Waleij, CEO of BrainCool

”This funding is not just a financial boost- it’s a vote of confidence in our vision and technology. It empowers us to push the boundaries of applied materials science, driving significant advancements in the pace of battery research and development. With this funding we can expand from the niche of electrolyte optimization to full battery design and eventually beyond the battery space, making our solutions more valuable for more companies. This is an exciting time for Compular and the wider industry, as we work together to meet the urgent demands of the green transition.”

Rasmus Andersson, CEO of Compular

“We are clearly in the forefront of RNA- seg based modern clinical diagnostics and with the funding we will develop solutions both for acute myeloid leukemia (AML) and bladder cancer with the objective to advance personalized cancer treatment. We express our appreciation for the expert assistance and guidance provided by GAEU Consulting in the development of our application within the EIC Accelerator program. The team at GAEU possesses a high level of proficiency in navigating this process, offering crucial feedback, and demonstrating a high level of knowledge. Working with GAEU has been a very positive experience.”

Carl-Johan Ivarsson, CEO of Qlucore AB

“Multi4 AB expresses appreciation for the expert assistance and guidance provided by GAEU Consulting in the development of application for the Women Leadership Program from the European Innovation Council. The team possesses a high level of proficiency in navigating the process, providing necessary feedback and demonstrating the expert level of knowledge. We think that working with GAEU is a great experience.”

Miden Melle Hannah, CEO at Multi4

“Inossia is extremely grateful for the professional help and support that we received from GAEU Consulting to create our application and prepare us for the interview. It is a delicate process which requires large experience and good insight in how these applications are evaluated. The GAEU team masters the EIC Accelerator process and has carried Inossia through all steps with a lot of patience and a few laughter. We could not have wished for better support!”

Malin Nilsson, CEO at Inossia

“This grant proves that Ligna has the right product to address the growing environmental concerns with the IoT sensors that are powered by millions of non-sustainable battery alternatives. In addition, we are very satisfied with the cooperation with GAEU and strongly recommend GAEU as a Eurostars funding advisor.”

Peter Ringstad, CEO at Ligna Energy

“The EIC Accelerator funding is coming at a time when it is most needed for our company. GAEU has been very supportive during the process and with their previous expertise and knowledge that gave us valuable feedback. The RondelO multi inlet stopcock manifold can now be developed to be able to reach the mass market, to improve the Infusion treatment to address the underserved but well recognized problem of drug incompatibility inline due to human error during administration.”

Micael Törnblom, CEO at Cyto365

"The EIC Accelerator is a very competitive call and creating a winning proposal on your own takes significant resources. We chose to partner with GAEU to help us create our winning proposal. I can highly recommend choosing GAEU as your partner - they are very professional and deliver high quality results. I was very impressed that they had the expertise to understand both our technology and business case."

Hans Salomonsson, CEO at EmbeDL

“During our large strategic review in 2021, we made the decision to start working systematically with our soft funding. During that review, we evaluated the best and most professional partners within the field and the decision landed on GAEU Consulting. The knowledge and drive that GAEU represents have proven to make a huge difference for us at SeaTwirl.”

Peter Laurits, CEO at SeaTwirl

“Working with GAEU was a true pleasure. Their thought-through and proven methodology of guiding you through the application process, step-by-step, was excellent. Applying for a grant of this size can be overwhelming for a small company like ours and with the consultants gradually guiding us through the process, this is a great way of actually reaching the end, getting the grant eventually.”

Jessika Broström, CEO at Lindhe Xtend AB

"I recommend GAEU Consulting as a trustworthy and competent advisor within Eurostars funding program. The funding we have received will help us to secure in vivo efficacy data, identify biomarkers for patient selection and treatment outcome follow-up. We will also design regulatory and toxicology programs allowing for a successful transition to clinical trials."

Moa Fransson, CEO at Genagon Therapeutics

“The GAEU team combines unique sets of skills by offering scientific and technical expertise together with project management and extremely solid financial analysis and funding/capital investment knowledge. Furthermore, they are wonderful people, very professional in their approach and always ready to support us whenever we needed them!”

Laura Chirica, CEO at Cellevate

“GAEU Consulting has provided professional guidance throughout the EIC accelerator application process. Their experience and knowledge are key success factors that lead to this positive outcome in the highly competitive EIC accelerator program.”

Annelie Lundström, CEO at Minalyze

“If you are considering applying for a grant, we can strongly recommend contact with GAEU, you not only get a company that helps you write an application, you get a partner who fights with you and does everything in their power for you to succeed!”

Miden Melle-Hannah, CEO at Multi4

“We at GreenIron have very much enjoyed working with GAEU. We perceive GAEU and its specialists to be very competent and friendly and it has been great to work with GAEU.”

Edward Murray, CEO at GreenIron

“We are very pleased with GAEU Consulting’s performance and we highly recommend the company for similar efforts. GAEU Consulting is an excellent advisor suited for excellent innovation projects in the Horizon 2020!”

Mats Grahn, CEO at Immunovia AB

“Collaborating with GAEU has been great! The team is very responsive, knowledgable, and supportive. Their work and efforts will help us ensure long term success. A company to depend on.”

Dr. Erik Gatenholm, CEO at Cellink

“We had less than a week to complete this application, and from previous experience of working with GAEU, we knew that they were the right partner for us. I’m impressed by their skills and how fast they grasped the essence of our rather complex project. They are not only dedicated, they are also pleasurable to work with. I look forward to working with them again.”

Johan Raud, CFO at Vicore Pharma

“The support we have received from GAEU has been very professional and dedicated in addition to it being a great pleasure on a personal level as well to collaborate with the entire GAEU-team on securing this very important EIC grant for Elicera.”

Jamal El-Mosleh, CEO at Elicera Therapeutics

Pixelgen Technologies, a Swedish deep tech company pioneering a new era of spatial proteomics and protein interactomics, has been awarded €12.5 million in blended funding from the European Innovation Council (EIC) Accelerator under the Horizon Europe program.

AlzeCure Pharma, a Swedish clinical-stage pharma company specializing in innovative treatments for central nervous system (CNS) disorders, has been awarded a €2.5 million grant from the European Innovation Council (EIC) Accelerator under the Horizon Europe program.

We are thrilled to announce that our client, POLBIONICA, has been awarded €2.5 million through Poland’s FENG Seal of Excellence EIC Accelerator funding program. This funding supports pioneering projects that have earned the Seal of Excellence from European Innovation Council and SMEs Executive Agency (EISMEA).

We are excited to announce that our client, Cocoon Airbag Protection AB, has been awarded grant funding from the Women TechEU program under Horizon Europe. This funding will accelerate the commercialization of Cocoon’s innovative child safety solution for bicycle transportation.

PharmNovo, a Swedish clinical-stage pharmaceutical company, has been awarded €17.5 million in blended funding from the European Innovation Council (EIC) Accelerator under the Horizon Europe program. The funding consists of a grant of €2.5 million and equity investments through the EIC Fund of up to €15 million, contingent upon securing equivalent funding from co-investors.

AlixLabs is proud to announce the receipt of a prestigious funding package worth €400,000 to develop a cutting-edge digitalization platform for APS Semiconductor technology. This significant financial boost marks a pivotal step in AlixLabs' journey towards revolutionizing the semiconductor industry, in collaboration with partners Nanovac and Imitera.

Compular is proud to announce the receipt of a prestigious funding package worth €5.3 million from the European Innovation Council (EIC) Accelerator, part of the Horizon Europe program. This significant financial boost is aimed at digitizing material development, with a particular focus on the battery industry, marking a pivotal step in Compular’s journey towards the market.

Qlucore, a pioneer in cancer diagnostic software development, has received a €2.5 million grant from the EIC Accelerator Horizon Europe to spearhead the development and eventual introduction of CE-marked software solutions targeted for AML and bladder cancer diagnoses. The project is centred on addressing the critical need for better diagnostics in malignancies with complicated RNA-level changes. Qlucore’s research, which uses RNA-based technologies, promises to open up new dimensions in cancer diagnosis and therapy, ensuring that patients receive the most effective treatments tailored to their unique needs.

“The loan agreement with EIB further validates BrainCool’s cutting-edge technology, underpinning our goal to become a major player in the medical device market. This agreement supports our ambitious plan to develop an extensive clinical pipeline of groundbreaking therapies, initially focusing on stroke, then expanding to sudden cardiac arrest and oncology. Throughout this process, GAEU Consulting has offered invaluable support, including strategic project advice, assistance during due diligence, and financial modelling expertise. We strongly recommend GAEU as a highly experienced EIB advisor.”

GAEU Consulting is thrilled to announce a record-breaking Vinnova funding round. Two of our esteemed clients: Ligna Energy AB and Johannas Stadsodlingar AB have been awarded a combined total of €2 million within the program “Upscaling for a sustainable industry 2023” to accelerate the scaling up of their innovative solutions aimed at tackling significant industrial and societal challenges. This funding represents an extraordinary achievement for GAEU Consulting within Vinnova programs – after last year’s Vinnova funding record, we have now set the bar for our team even higher.

GAEU Consulting is pleased to announce that our client, IPercept Technology AB, has been awarded SEK 3,527,800 within Vinnova's program for Advanced and Innovative Digitalisation to develop machine-configurable AI for industrial tool wear and process monitoring. The project will be performed in cooperation with partners from academia and industry, and it is an important step towards enabling the transition towards Industry 4.0 in Sweden and internationally. The groundbreaking technology will provide industrial manufacturers with the means to monitor the performance and wear and tear of their critical equipment.

We are thrilled to announce that our client, Multi4 Medical AB, has been awarded grant funding from Women TechEU, Horizon Europe to accelerate the commercialization of its groundbreaking surgical instrument for the diagnosis and treatment of bladder cancer. Multi4 is the first company in the world to successfully develop automated technology for endoscopic cancer diagnosis and treatment, and its new and patented technology has the potential to be a game changer for millions of patients worldwide.

GAEU Consulting is delighted to announce that Tendo AB, our esteemed client, has been awarded a grant from “Swelife and Medtech4Health - Collaboration projects for better health autumn 2022.” The grant of SEK 3 M (EUR 300k) has been allocated for the clinical validation and development of a generic version of Tendo OneGrip, ahead of CE marking. The project will be executed in collaboration with partners in the domains of electronics development and clinical studies.

GAEU Consulting is pleased to announce another success story within the EIC Accelerator of Horizon Europe. Our client, Inossia, has been awarded €7.3 million within the Blended Finance scheme of the EIC Accelerator (€2.3 million in grant funding and €5 million in equity) to clinically validate two new bone cements using the Inossia® Cement Softener: V-Flex for spinal fractures and Elastoment for degenerated discs.

Ligna Energy and GPBM France receive a prestigious Eurostars grant to co-develop new IoT sensor applications based on Ligna’s revolutionary green storage technology in which organic materials replace traditional battery components. The partners aim to tap into a strong business opportunity in supplying the blooming IoT industry with sustainable and greener technology alternatives. The total funding awarded amounts to EUR 630k.

As the year 2022 is slowly coming to an end, we stop to look back at our achievements in 2022. It has been a busy year for our team! We have been fighting for grants on several fronts, very often to cut-offs and deadlines that fall on the same date, within a broad variety of funding mechanisms: Horizon Europe, EIC Accelerator, Eurostars, Vinnova, EIT Health, Energimyndigheten, you name it! And with what results! We have broken new grounds and set new funding records for our company. Those records will be hard to beat but we will try! We have a fantastic team, full of committed, super-skilled and passionate people that take our quality promise to our Clients very seriously. This is reflected in the results we deliver.

In the last cut-off for 2022, two GAEU Consulting clients have made it to the winners list: EmbeDL - a spin-off from the Horizon 2020 funded research project LEGaTO. The mission of EmbeDL is to commercialise its Deep Learning optimisation engine into a highly scalable service that makes DL-based AI affordable and energy efficient in embedded systems. Cyto356 - a medical-device start-up developing RondelO™ - a globally unique medical stopcock that prevents mixing of drugs. RondelO™ combats drug incompatibility by design, and it is the only physical device that adds an extra layer of safety for the nurse to do right.

GAEU Consulting supported SeaTwirl in developing the grant proposal to the Swedish Energy Agency. SeaTwirl receives 50.4 MSEK (approx. 5 MEUR) in grant funding within the program “Larger pilot and demonstration projects for energy and climate change transition”. The grant will allow SeaTwirl to install its 1 MW S2x turbine in Norway for demonstration and testing purposes.